Skip to content
Linkly
Sector · Pharma & medtech

Linkly for pharma manufacturers, CMOs and medical devices.

Pharmintech, CPHI Milan, Exposanità, Expodental, Welfair: highly regulated sectors where every lead requires privacy compliance plus traceability plus approved technical material. Linkly is the first booth lead-capture system with full GDPR audit trail.

Sector in target for Linkly: pharma manufacturers (large plus medium), CMO/CPO, vendors of pharma packaging machinery, ingredients, aseptic automation, B2B medical devices.

Sector pain points

What slows down your trade fair returns today.

Pain 01

The pharma buyer wants complete technical specs plus certifications plus case studies with the client named (NDA permitting). Without pre-approved material at the booth, every email requires legal review.

Pain 02

Triple audience: internal pharma buyer, R&D/regulatory affairs, commercial CMO. Treating R&D as a buyer is a serious mistake that burns the relationship.

Pain 03

GDPR plus GMP audit: every contact must have a documented legal basis, every sent email tracked, every record deletable on request. Generic systems are not enough.

Pain 04

Pharmintech is triennial (2025, 2028). In the intermediate years you need structured nurturing to avoid disappearing. Without event-driven CRM, the pipeline goes cold.

Why Linkly inPharma & medtech

The typical use case: a pharma contract manufacturer at Pharmintech Milano.

In pharma, Linkly provides a complete GDPR audit trail for every lead: documented legal basis for processing, traced data source, registered opt-ins. The follow-up email goes out from the verified company domain (DMARC, DKIM, SPF) with technical material pre-approved before the event. Enrichment distinguishes critical pharma roles (buyer / regulatory / R&D / quality) and triggers separate workflows. Data deletion is also automatic and traceable.

Linkly in Italian B2B pharma

Italian B2B pharma is dominated by triennial and biennial trade fairs with a highly qualified audience: Pharmintech Milano (triennial 2028), CPHI Milan (October, annual), Exposanità Bologna (healthcare, biennial), Expodental Rimini (dentistry, annual), Welfair Roma (healthcare-as-a-service, annual).

The Linkly pharma customer has specific characteristics:

  • 2-5 trade fairs per year (Italy plus EU, CPHI Worldwide rotates among European cities)
  • Events budget 80k-500k EUR (premium image is mandatory)
  • Technical sales team (5-20 at the booth): area sales plus R&D plus regulatory plus quality
  • CRM in use: Salesforce, Veeva CRM (pharma-specific), SAP CRM
  • Critical compliance: GDPR, GMP audit trail, FDA/EMA
  • Main pain: follow-up speed vs. legal control of material

The Linkly operating pattern for pharma

Pre-event:

  1. Technical materials pre-approved by legal and regulatory loaded into Linkly
  2. Separate workflows for buyer / R&D / regulatory / quality / press
  3. Competitor exclusion list configured
  4. GDPR audit trail activated for every contact

During:

  1. Scan, enrichment with specific role (buyer/R&D/regulatory) plus company plus certifications
  2. Quick qualification form with declared legal basis for processing
  3. Outreach Agent sends the pre-approved material matching the role

Post-event:

  1. Analytics: pipeline by product line, conversion by persona, complete audit trail
  2. Quarterly nurturing for the long cycle (12-36 months typical in pharma): new case studies, scientific papers, participation in related congresses

Typical result

  • 100% of leads with complete GDPR audit trail (vs. manual leads on Excel that are not compliant)
  • 30-50% reduction in follow-up time (from weeks to days thanks to pre-approved materials)
  • Triennial pipeline tracked: even in years without Pharmintech, the funnel does not cool down

The value for the pharma sales director

The pharma sales director lives with three constraints: long cycle (12-36 months), demanding technical audience (specs, certifications, case studies) and pervasive compliance. Linkly solves the third constraint (automatic compliance) and accelerates the first (structured nurturing) without compromising the second (pre-approved materials). Pharmintech ROI finally becomes defensible to the CFO with tracked numbers.

Key Linkly agents for your sector

Start with these 2 agents.

Agent 02

Enrichment Agent

Automatically distinguishes buyer from R&D, regulatory affairs and quality assurance. Critical in pharma, where the wrong workflow burns months of relationship. Also retrieves company certifications, FDA/EMA status, manufacturing capacity.

Agent 06

Analytics Agent

Executive report with event ROI defensible to the CFO (Pharmintech costs 50-130k EUR). Estimated pipeline by product line, conversion rate by persona, top buyer source countries.

Main trade fairs in your sector

The dedicated Linkly operational guides.

FAQs specific toPharma & medtech

The most frequently asked questions.

Can we verify the GDPR audit trail with our DPO?
Yes. Linkly provides full documentation: legal basis for each lead, consultable audit-trail log, GDPR processes documented in the Article 28 DPA signed before activation. Your DPO can review pre-go-live and at any later point.
Can we automatically exclude competitors from follow-up?
Yes. Exclusion list configured during onboarding. When the sales rep scans a badge of a company on the list, Linkly digitizes the contact but does NOT trigger the automated follow-up workflow. The lead stays in the CRM for internal visibility without automated touchpoints.
We handle anonymized patient data for case studies. Does Linkly process clinical data?
No. Linkly is designed for B2B commercial data, not clinical data. Case studies and materials you use for follow-up must be pre-approved and free of identifiable patient data. The document approval pipeline stays in your hands (internal compliance).

Let's configure Linkly for your next Pharma & medtech.

30-minute demo with a consultant. We configure a real event from your calendar together.

Go deeper with AI

Linkly pages are optimised to be read correctly by AI assistants. Open the conversation in your preferred one with the context already in place, or copy the prompt to use it anywhere.